Author

Oliver Klein

Doctor of Medical Science, Proteomics Unit Charit

Biography

Dr Oliver Klein has undertaken his training in Medical Oncology and Clinical Haematology in Germany before coming to Australia in 2005 to join the Ludwig Institute for Cancer Research at the Austin Hospital. He has worked for several years as a postdoctoral and clinical research fellow being actively involved in melanoma and cancer immunotherapy research. Dr Klein has extensive experience in the management of patients with melanoma and a particular interest in immuno-oncology. He has lead an investigator initiated clinical trial that demonstrated unprecedented clinical efficacy of immunotherapy using checkpoint inhibitors in patients with advanced rare cancers.
Title
Cited by
Year
Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts
C Tschöpe, S Van Linthout, O Klein, T Mairinger, F Krackhardt, ...Journal of cardiovascular translational research 12, 116-123, 2019201
126
2019
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
C Tschöpe, B Kherad, O Klein, A Lipp, F Blaschke, D Gutterman, ...European journal of heart failure 21 (1), 14-22, 2019201
78
2019
MALDI‐imaging for classification of epithelial ovarian cancer histotypes from a tissue microarray using machine learning methods
O Klein, F Kanter, H Kulbe, P Jank, C Denkert, G Nebrich, WD Schmitt, ...PROTEOMICS–Clinical Applications 13 (1), 1700181, 2019201
68
2019
Collagen fibrils mechanically contribute to tissue contraction in an in vitro wound healing scenario
E Brauer, E Lippens, O Klein, G Nebrich, S Schreivogel, G Korus, ...Advanced Science 6 (9), 1801780, 2019201
51
2019
Mode-of-action of the PROPELLA concept in fulminant myocarditis
F Spillmann, S Van Linthout, G Schmidt, O Klein, N Hamdani, T Mairinger, ...European heart journal 40 (26), 2164-2169, 2019201
50
2019
Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity
S Van Linthout, A Elsanhoury, O Klein, M Sosnowski, K Miteva, D Lassner, ...ESC heart failure 5 (5), 818-829, 2018201
34
2018
Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy
KN Mhatre, P Wakula, O Klein, E Bisping, J Völkl, B Pieske, FR HeinzelCellular and Molecular Life Sciences 75, 4403-4416, 2018201
34
2018
Regenerative potential of adipocytes in hypertrophic scars is mediated by myofibroblast reprogramming
K Hoerst, L van den Broek, C Sachse, O Klein, U von Fritschen, S Gibbs, ...Journal of Molecular Medicine 97, 761-775, 2019201
28
2019
Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes
CM Beez, M Haag, O Klein, S Van Linthout, M Sittinger, M SeifertJournal of Nanobiotechnology 17, 1-18, 191
20
2019
Unraveling local tissue changes within severely injured skeletal muscles in response to MSC-based intervention using MALDI Imaging mass spectrometry
O Klein, K Strohschein, G Nebrich, M Fuchs, H Thiele, P Giavalisco, ...Scientific Reports 8 (1), 12677, 202
18
2018
The human liver matrisome–Proteomic analysis of native and fibrotic human liver extracellular matrices for organ engineering approaches
A Daneshgar, O Klein, G Nebrich, M Weinhart, P Tang, A Arnold, I Ullah, ...Biomaterials 257, 120247, 2020202
17
2020
Speckle-tracking echocardiography combined with imaging mass spectrometry assesses region-dependent alterations
K Pappritz, J Grune, O Klein, N Hegemann, F Dong, M El-Shafeey, J Lin, ...Scientific reports 10 (1), 3629, 2020202
14
2020
Classification of molecular subtypes of high-grade serous ovarian cancer by MALDI-imaging
W Kassuhn, O Klein, S Darb-Esfahani, H Lammert, S Handzik, ET Taube, ...Cancers 13 (7), 15, 2021202
12
2021
Discovery of prognostic markers for early-stage high-grade serous ovarian cancer by maldi-imaging
H Kulbe, O Klein, Z Wu, ET Taube, W Kassuhn, D Horst, S Darb-Esfahani, ...Cancers 12 (8), 2000, 2020202
11
2020
Imaging mass spectrometry for characterization of atrial fibrillation subtypes
O Klein, T Hanke, G Nebrich, J Yan, B Schubert, P Giavalisco, F Noack, ...PROTEOMICS–Clinical Applications 12 (6), 1700155, 2018201
11
2018
The spontaneous course of human herpesvirus 6 DNA-associated myocarditis and the effect of immunosuppressive intervention
A Elsanhoury, U Kühl, B Stautner, O Klein, A Krannich, D Morris, M Willner, ...Viruses 14 (2), 299, 2022202
8
2022
Discovery of spatial peptide signatures for neuroblastoma risk assessment by MALDI mass spectrometry imaging
Z Wu, P Hundsdoerfer, JH Schulte, K Astrahantseff, S Boral, K Schmelz, ...Cancers 13 (13), 314, 2021202
8
2021
Classification of Inflammatory Bowel Disease from Formalin‐Fixed, Paraffin‐Embedded Tissue Biopsies via Imaging Mass Spectrometry
O Klein, F Fogt, S Hollerbach, G Nebrich, T Boskamp, A WellmannPROTEOMICS–Clinical Applications 14 (6), 1900131, 2020202
8
2020
Increased presence and differential molecular imprinting of transit amplifying cells in psoriasis
K Witte, K Jürchott, D Christou, J Hecht, G Salinas, U Krüger, O Klein, ...Journal of Molecular Medicine 9, 111-122, 2020202
8
2020
In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging
M Grzeski, ET Taube, EI Braicu, J Sehouli, V Blanchard, O KleinCancers 14 (4), 1021, 2022202
7
2022

Referred From: https://scholar.google.com/citations?user=03Qpoi8AAAAJ&hl=en&oi=sra

Cited by
Citations 1453
h-index 20
i10-index 35
Recommended Journals
Open Access Journals